An animal study reported reduced serum interleukin-6 (IL-6), high mobility group protein B1 (HMGB)-1, and tumor necrosis factor-α(TNF-α) levels but increased interleukin-10 (IL-10) levels in the group given esmolol compared with the sepsis group [30]. This evidence concerns the gene IL6 and Sepsis.